Company / Capital Expenditures
PROKIDNEY CORP. Capital Expenditures History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$29.5M
FY2024
5-year range
$1.8M / $34.2M
FY2020-FY2024
Trend
-13.7%
vs FY2023
Sector context
#36 of 194
Health Care
What the data says
PROKIDNEY CORP.'s capital expenditures of $30M is higher than 81% of companies in the Health Care sector (FY2024). Improved from $2M to $30M over the past 2 years.
Based on SEC 10-K filings.
$30M in FY2024 with a 3-year CAGR of +78.5%. Top quartile in the Health Care sector.
Improved from $2M to $30M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +78.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 194This company $29.5M Sector average $117.5M
▼
-74.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +78.5%, indicating consistent growth.
- In FY2024, capital expenditures decreased 13.7% year-over-year.
- Ranks #36 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $29.5M | -13.7% |
| FY2023 | $34.2M | +1752.5% |
| FY2022 | $1.8M | -64.4% |
| FY2021 | $5.2M | -4.8% |
| FY2020 | $5.5M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026